First AD

Second AD

Pathophysiology of Hypercholesterolemia and Cardiovascular Disease 

Risk Factors for Developing Hyperlipidemia 

Identifying Patients at High Risk for CV Morbidity and Mortality 

High Cholesterol Versus Familial Hypercholesterolemia 

Aggressive LDL Lowering in High-Risk Patients 

Mechanism of Action of Inclisiran in Lipid Lowering  

Outcomes and Practical Implications of Newer Agents 

EPA in the Prevention of CV Risk 

Emerging Use of Inclisiran as Adjunct Therapy in Hyperlipidemia 

Phase 3 ORION Trials for Inclisiran 

Peer Exchange

Videos

Lipid Management

Lipid Management condition center page, resources on the topics of medical news and expert insight into lipidology can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dyslipidemia research, treatment, and drug development.

Expert panel of cardiologists provide their perspective on the specific population that may be at a risk of developing hyperlipidemia. 

Expert cardiologists provide a brief overview of the standard of care for lipid disorders and focus on a rapidly emerging, newer treatment option for managing dyslipidemia.

Paradigm Shifts in Lipid Lowering